EP1173171A1 - Nouvelle composition injectable d'un anticoagulant - Google Patents
Nouvelle composition injectable d'un anticoagulantInfo
- Publication number
- EP1173171A1 EP1173171A1 EP00922734A EP00922734A EP1173171A1 EP 1173171 A1 EP1173171 A1 EP 1173171A1 EP 00922734 A EP00922734 A EP 00922734A EP 00922734 A EP00922734 A EP 00922734A EP 1173171 A1 EP1173171 A1 EP 1173171A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- citric acid
- solution
- sodium citrate
- injectable composition
- injectable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
Definitions
- the solutions may possibly contain other excipients normally used in injections.
- the weighings as well as the filtrations are carried out in an inactinic room and the preparation is carried out in a stainless steel tank, fitted with a motor and a turbine speed variator.
- DX 9065a, citric acid, sodium citrate and sodium chloride are added in 67% of the total amount of PPI water present in the final formula, then the final volume is adjusted with PPI water .
- the dissolution takes place for 20 minutes at room temperature, with stirring at 205 rpm.
- the solution is collected in a stainless steel beaker and then filtered through Millipack 20.
- the sterile solution is distributed in 3 ml brown glass vials, at a rate of 2.2 ml per vial to give a unit composition as described in TABLE 2 below.
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9905345 | 1999-04-26 | ||
FR9905345A FR2793687B1 (fr) | 1999-04-26 | 1999-04-26 | Nouvelle composition injectable d'un anticoagulant |
PCT/FR2000/001083 WO2000064442A1 (fr) | 1999-04-26 | 2000-04-25 | Nouvelle composition injectable d'un anticoagulant |
Publications (1)
Publication Number | Publication Date |
---|---|
EP1173171A1 true EP1173171A1 (fr) | 2002-01-23 |
Family
ID=9544937
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP00922734A Withdrawn EP1173171A1 (fr) | 1999-04-26 | 2000-04-25 | Nouvelle composition injectable d'un anticoagulant |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1173171A1 (fr) |
JP (1) | JP2002542288A (fr) |
AU (1) | AU4303300A (fr) |
CA (1) | CA2370576A1 (fr) |
FR (1) | FR2793687B1 (fr) |
WO (1) | WO2000064442A1 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050187249A1 (en) * | 2002-05-13 | 2005-08-25 | Daiichi Pharmaceutical Co., Ltd. | Lypohilization product |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ZA928276B (en) * | 1991-10-31 | 1993-05-06 | Daiichi Seiyaku Co | Aromatic amidine derivates and salts thereof. |
JPH092977A (ja) * | 1995-06-21 | 1997-01-07 | Dai Ichi Seiyaku Co Ltd | 経口投与用医薬組成物 |
WO1998003202A1 (fr) * | 1996-07-23 | 1998-01-29 | Daiichi Pharmaceutical Co., Ltd. | Agents absorptifs |
CA2275475A1 (fr) * | 1996-12-19 | 1998-06-25 | Hiroshi Kikuchi | Composition pharmaceutique pour administration par voie orale |
FR2764511B1 (fr) * | 1997-06-13 | 2000-09-08 | Sanofi Sa | Compositions pour le traitement et la prevention de la thrombose arterielle et utilisation d'un inhibiteur du facteur xa seul et/ou en combinaison avec un antiagregant plaquettaire |
JPH1180032A (ja) * | 1997-09-12 | 1999-03-23 | Dai Ichi Seiyaku Co Ltd | 複合体 |
-
1999
- 1999-04-26 FR FR9905345A patent/FR2793687B1/fr not_active Expired - Fee Related
-
2000
- 2000-04-25 WO PCT/FR2000/001083 patent/WO2000064442A1/fr not_active Application Discontinuation
- 2000-04-25 EP EP00922734A patent/EP1173171A1/fr not_active Withdrawn
- 2000-04-25 CA CA002370576A patent/CA2370576A1/fr not_active Abandoned
- 2000-04-25 AU AU43033/00A patent/AU4303300A/en not_active Abandoned
- 2000-04-25 JP JP2000613433A patent/JP2002542288A/ja active Pending
Non-Patent Citations (1)
Title |
---|
See references of WO0064442A1 * |
Also Published As
Publication number | Publication date |
---|---|
AU4303300A (en) | 2000-11-10 |
FR2793687A1 (fr) | 2000-11-24 |
FR2793687B1 (fr) | 2001-08-24 |
WO2000064442A1 (fr) | 2000-11-02 |
JP2002542288A (ja) | 2002-12-10 |
CA2370576A1 (fr) | 2000-11-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0858329B1 (fr) | Nouvelles formulations liquides stables a base de paracetamol et leur mode de preparation | |
KR101202649B1 (ko) | 소듐 디클로페낙 및 β-시클로덱스트린을 포함하는 주사용약학 조성물 | |
US4628053A (en) | Stabilized injectable solutions of piroxicam | |
FR2670487A1 (fr) | Nouveau sel de 3-[2-dimethylamino)ethyl-]-n-methyl-1h-indole-5-methanesulfonamide, sa preparation et son utilisation comme medicament. | |
NO174916B (no) | Fremgangsmåte for fremstilling av et medikament for behandling av öyenbetennelser | |
EP0336200B1 (fr) | Compositions pharmaceutiques à base de piroxicame en solution aqueuse et procédé pour les préparer | |
EP0055029B1 (fr) | Préparations pour le traitement de dermatoses | |
PT1368019E (pt) | Formulação de esmolol | |
RU2062616C1 (ru) | Жидкая лекформа пироксикама | |
RU2286774C2 (ru) | Препарат эсмолола | |
PT1694660E (pt) | Processo de preparação de ingredientes farmacêuticos activos (api) anidros e hidratados; composições farmacêuticas estáveis preparadas a partir dos mesmos e utilizações das referidas composições | |
CN1125635C (zh) | 恩氟沙星注射液或输液 | |
JPH055810B2 (fr) | ||
KR900012892A (ko) | 항-염증성 아릴 화합물 | |
EP0244315A1 (fr) | Procédé de préparation d'une solution pharmaceutique aqueuse d'un principe actif constitué par un acide organique | |
FR2681863A1 (fr) | Solution de sparfloxacine sa preparation et sel la constituant. | |
EP1105102A1 (fr) | Composition pharmaceutique injectable a base d'un sel pharmaceutiquement acceptable du clopidogrel ou de ticlopidine | |
LU82360A1 (fr) | Compositions injectables a base d'oxytetracycline | |
HU198839B (en) | Process for producing aqueous compositions comprising hydroxy-alkadiinyl-benzoquinone derivatives as active ingredient | |
WO2000064442A1 (fr) | Nouvelle composition injectable d'un anticoagulant | |
PT85612B (pt) | Processo para a preparacao de composicoes farmaceuticas liofilizadas contendo acidos fenilquinolinocarboxilicos | |
US5344941A (en) | Water soluble salts of thionaphthene-2-carboxylic acid | |
BE1007420A3 (fr) | Ampoules et solution de perfusion d'acides thioctique sous forme de sels solubles dans l'eau d'acide thioctique. | |
CN1034132A (zh) | 含哌啶基环戊基庚烯酸衍生物的水溶液配方 | |
JPH0135804B2 (fr) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20011019 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE |
|
AX | Request for extension of the european patent |
Free format text: AL;LT;LV;MK;RO;SI |
|
RIN1 | Information on inventor provided before grant (corrected) |
Inventor name: MAFUNE, EIICHI, DAIICHI PHARMACEUTICAL CO., LTD. Inventor name: FUJII, YOSHIMINE, DAIICHI PHARMACEUTICAL CO., LTD Inventor name: BREUL, THIERRY |
|
17Q | First examination report despatched |
Effective date: 20040202 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20040614 |